Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Saturday, October 15, 2011

FDA and Community-Acquired Pneumonia - GETTING THERE.

›
As I noted earlier this week, The FDA has just announced two days of advisory committee meetings on clinical trial design in pneumonia. Nov...
Tuesday, October 11, 2011

FDA and Pneumonia - Here We Go Again!

›
The FDA has just announced two days of advisory committee meetings on clinical trial design in pneumonia. November third will cover communit...
Tuesday, October 4, 2011

From the Pew Charitable Trusts - 2

›
This is the second (longer than usual) installment from the meeting at Pew Charitable Trust, September 22, 2011 .  In this installment, I r...
Thursday, September 22, 2011

Antibiotics in 2020 - A Vision - Reporting from the Pew Charitable Trust

›
Image via Wikipedia This is the first installment from a fascinating meeting at Pew Charitable Trust, September 22, 2011 .  ·       Reve...
Sunday, September 18, 2011

Hope from ICAAC 2011

›
Image via Wikipedia Hello out there in blog-land.  I am writing from the 51 st ICAAC here in Chicago.  David Livermore gave an opening add...
1 comment:
Sunday, September 11, 2011

BARDA "Pushes" the Envelope

›
In several previous blogs , I noted how important funding Phase III trials would be to incentivize the industry to work on new antibiotics. ...
Monday, September 5, 2011

Conundrum

›
I have been invited to participate in a meeting later in September  where the FDA, congressional staffers, the pharmaceutical industry large...
6 comments:
‹
›
Home
View web version
Powered by Blogger.